Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myocet in Children With Relapsed or Refractory Non-brainstem Malignant Glioma
NCT02861222Phase 1Completed
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Oct 2010
- Primary completion
- Apr 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of doxorubicin in malignant glioma, sponsored by CHRU de Nancy - Hôpital Central. Primary endpoints: General health evaluation, Changes in neurological condition related to the tumor and 4 more. Started Oct 2010; status: completed.
02
Drugs
doxorubicin
03
Conditions
malignant glioma
Beyond the preview
Go deeper on NCT02861222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02861222.